CONTEXT
Among the multiple comorbidities associated with substance use disorders and injection, hepatitis C (HCV) and chronic non-cancer pain (CNCP) (i.e. intermittent or continuous pain for more than 3 months) are frequent and often coexisting conditions that cause a significant societal burden. The modalities of peer support in these conditions among people who use psychoactive substances by injection have been understudied, particularly in Quebec.
Objectives
- Characterize the experience of chronic pain among people who inject substances and advance knowledge about the relationship between pain, substance use, and subsequent adverse outcomes.
- Co-construct a peer approach to improve the well-being and engagement in health and care of people who inject substances and are struggling with hepatitis C and/or chronic pain.
Funding
- Canadian Institutes of Health Research
- Health Canada
- Ministère de la santé et des services sociaux du Québec
- Institut universitaire sur les dépendances
- CIUSSS du Centre-Sud de l’Île de Montréal
Principal investigator
Co-investigator and collaborators
- Karine Bertrand, PhD
- Jémima-Farrah Bourdeau, MD
- Manon Choinière, PhD
- Lise Dassieu, PhD
- Stine Hoj, PhD
- Didier Jutras-Aswad, PhD
- Valérie Martel-Laferrière, MD, MSc
- Jean-François Mary, MSc,
- Sarah Larney, PhD
- Gabrielle Pagé, PhD
- Marie-Pierre Sylvestre, PhD